May 02, 2016

MEDTECH ANNOUNCES FIRST ROSA SPINE SURGERY IN THE UNITED STATES

ROSA® Spine Facilitates Spinal Fusion Procedure at Miami Valley Hospital

 

Montpellier, France, May 2, 2016 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced the first surgical operation with the ROSA® Spine in the U.S. was performed at Miami Valley Hospital, a nationally recognized medical facility in Dayton, Ohio. Miami Valley Hospital was the first site to acquire ROSA® Spine in the U.S. following FDA clearance in January 2016.

The operation was performed by Dr. Juan Torres-Reveron, a neurosurgeon at Miami Valley Hospital. The patient presented symptoms associated with ongoing lumbar and leg pain and was treated with a spinal fusion procedure utilizing ROSA® Spine.  

“Premier Health has long been a leader in bringing these advanced technologies to patients," said Mark Shaker, president and Chief Executive Officer of Miami Valley Hospital.  "We are extremely proud of our team of highly trained clinicians including physicians, nurses, other professionals, and support staff all working together to provide this level of care for the region."

ROSA® Spine was granted FDA clearance in the U.S. in January 2016, and received the CE Mark in 2014. Medtech’s ROSA® Brain received FDA approval in 2012 and is currently in use in 29 U.S. facilities.

“We are proud to officially have ROSA® Spine in use in the U.S.,” said Bertin Nahum, CEO and founder of Medtech. “This technology allows surgeons to perform minimally invasive surgical procedures on the spine and increases the safety and reliability of the operations. The American market is the world’s leading market for spinal surgery, and this expansion will allow us to benefit a greater number of patients.”